The impact of primary human papillomavirus screening on negative loop excision histology following biopsy‐proven high‐grade cervical intra‐epithelial lesions: A review from a large tertiary colposcopy unit-Reference-Cited by-同舟云学术

The impact of primary human papillomavirus screening on negative loop excision histology following biopsy‐proven high‐grade cervical intra‐epithelial lesions: A review from a large tertiary colposcopy unit

Published:2021-09-10 Issue:6 Volume:61 Page:941-948
ISSN:0004-8666
Container-title:Australian and New Zealand Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Aust N Z J Obstet Gynaecol

Author:

Xie Huan¹^ORCID,Morton Rhett¹^ORCID,Balendran Jananie²^ORCID,Philp Shannon³^ORCID,Saidi Samir¹^ORCID,Farrell Rhonda¹^ORCID,Anderson Lyndal⁴^ORCID,Pather Selvan¹^ORCID

Affiliation:

1. Lifehouse Gynaecological Oncology Group Chris O’Brien Lifehouse Sydney New South WalesAustralia

2. Department of Gynaecology and Obstetrics Royal Prince Alfred Hospital Sydney New South WalesAustralia

3. Lifehouse Gynaecological Oncology Group Chris O’Brien LifehouseSusan Wakil School of NursingSydney Nursing SchoolThe University of Sydney Sydney New South WalesAustralia

4. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital Sydney New South Wales Australia

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajo.13426

Reference24 articles.

1. NCSP.National cervical screening program: guidelines for the management of screen detected abnormalities screening in specific populations and investigation of abnormal vaginal bleeding(2017). [https://wiki.cancer.org.au/australia/Guidelines:Cervical_cancer/Screening]. [updated Jan 2021].

2. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

3. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

4. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

5. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination